IDiyas

For the Inventor, By the Inventor

Needham, MA, United States of America

Andrew D Jones

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 5.3

ph-index = 3

Forward Citations = 29(Granted Patents)


Location History:

  • Lexington, MA (US) (2006)
  • Boston, MA (US) (2006 - 2009)
  • Needham, MA (US) (2009 - 2016)

Company Filing History:

goldMedal5 out of 1,149 
 
Vertex Pharmaceuticals, Inc.
 patents
silverMedal4 out of 1,829 
 
Schering Corporation
 patents
bronzeMedal2 out of 136 
 
Concert Pharmaceuticals, Inc.
 patents
4. 1 out of 1,500 
 
Astrazeneca Ab
 patents

Years Active: 2006-2016

Loading Chart...
Loading Chart...
12 patents (USPTO):
1. 9315483 - Synthesis of deuterated catechols and benzo[D][1,3]dioxoles and derivatives thereof (2016-04-19),
2. 8822498 - Synthesis of deuterated catechols and benzo[D][1,3]dioxoles and derivatives thereof (2014-09-02),
3. 8293929 - Processes and intermediates (2012-10-23),
4. 7834200 - Processes and intermediates (2010-11-16),
5. 7777048 - Processes for preparing biaryl ureas and analogs thereof (2010-08-17),
6. 7601833 - Process for preparing substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines (2009-10-13),
7. 7544810 - Processes for preparing biaryl ureas and analogs thereof (2009-06-09),
8. 7439361 - Process for preparing substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines (2008-10-21),
9. 7381827 - Processes and intermediates (2008-06-03),
10. 7223861 - Process for preparing substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidines (2007-05-29),
11. 7012145 - Method (2006-03-14),
12. 6992189 - Synthesis of piperidine and piperazine compounds as CCR5 antagonists (2006-01-31),

Title: The Innovative Contributions of Andrew D. Jones

Introduction

Andrew D. Jones, a prominent inventor based in Needham, Massachusetts, has made significant strides in the field of chemical synthesis. With an impressive portfolio of 12 patents, Jones is recognized for his innovative approaches to the production of complex chemical compounds.

Latest Patents

Among his latest contributions, Jones has developed methods for the "Synthesis of deuterated catechols and benzo[D][1,3]dioxoles and derivatives thereof." This invention addresses a need for a convenient and efficient process for synthesizing d-benzo[d][1,3]dioxoles, showcasing his dedication to advancing chemical practices.

Career Highlights

Throughout his career, Jones has worked with leading companies in the pharmaceutical industry, including Vertex Pharmaceuticals, Inc. and Schering Corporation. His expertise in chemical synthesis has contributed to important innovations that benefit the industry at large.

Collaborations

Jones has also collaborated with notable colleagues, including Philip L. Nyce and John R. Snoonian. These partnerships highlight not only his collaborative spirit but also the synergistic relationships that often drive innovation in research and development.

Conclusion

In conclusion, Andrew D. Jones stands out as an inventor whose contributions to chemical synthesis have important implications for the pharmaceutical industry. As he continues to innovate, the effects of his work may lead to further advancements that will enhance the field and provide solutions for future challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…